Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment
Stéphanie Andrade, Maria João Ramalho, Maria do Carmo Pereira, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Potential Adverse Effects of Resveratrol: A Literature Review
Abdullah Shaito, Anna Maria Posadino, Nadin Younes, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2084-2084
Open Access | Times Cited: 496
Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
Mehdi Sharifi‐Rad, Chintha Lankatillake, Daniel A. Dias, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 209
Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
Stéphanie Andrade, Maria João Ramalho, Joana A. Loureiro, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2313-2313
Open Access | Times Cited: 201
Role of natural products for the treatment of Alzheimer's disease
Tayebeh Noori, Ahmad Reza Dehpour, Antoni Sureda, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173974-173974
Closed Access | Times Cited: 117
Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It?
Mohamed Salla, Nadine Karaki, Belal El Kaderi, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 569-569
Open Access | Times Cited: 24
Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent
Muhammad Ali, Viviana Benfante, Domenico Di Raimondo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 126-126
Open Access | Times Cited: 20
Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
Fatih Çiftçi, Ali Can Özarslan, İmran Cagri Kantarci, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 121-121
Open Access | Times Cited: 2
Baicalein Exerts Neuroprotective Effects in FeCl3-Induced Posttraumatic Epileptic Seizures via Suppressing Ferroptosis
Qin Li, Qiu-Qi Li, Ji-Ning Jia, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 131
<p>Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer</p>
Mengdan Zhao, Junqin Li, Fengying Chen, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 9453-9467
Open Access | Times Cited: 89
Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease
Heng‐Chung Kung, Kai-Jung Lin, Chia‐Te Kung, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 918-918
Open Access | Times Cited: 89
The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
Terézia Kisková, Peter Kubatka, Dietrich Büsselberg, et al.
Biomolecules (2020) Vol. 10, Iss. 1, pp. 161-161
Open Access | Times Cited: 72
Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer’s disease
Samah Labban, Badrah S. Alghamdi, Fahad S. Alshehri, et al.
Behavioural Brain Research (2021) Vol. 402, pp. 113100-113100
Open Access | Times Cited: 67
Enhancement of blood–brain barrier penetration and the neuroprotective effect of resveratrol
Nikita Katila, Ramesh Duwa, Sunil Bhurtel, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 1-19
Closed Access | Times Cited: 54
Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction
Ekta Yadav, Pankajkumar Yadav, Mohd Masih Uzzaman Khan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 44
Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
The Pharmacological Properties of Red Grape Polyphenol Resveratrol: Clinical Trials and Obstacles in Drug Development
Mohd Farhan, Asim Rizvi
Nutrients (2023) Vol. 15, Iss. 20, pp. 4486-4486
Open Access | Times Cited: 34
Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective
Dur e Nayab, Fakhar ud Din, Hussain Ali, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Niraj Kumar Jha, Niraj Kumar Jha, Mohana Vamsi Nuli, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102224-102224
Closed Access | Times Cited: 14
Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence
Katarzyna Socała, Elżbieta Żmudzka, Klaudia Lustyk, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1400-1461
Closed Access | Times Cited: 11
Mitochondrial mechanisms in Cerebral Ischemia-Reperfusion Injury: Unravelling the intricacies
Shiv Kumar Saini, Damanpreet Singh
Mitochondrion (2024) Vol. 77, pp. 101883-101883
Closed Access | Times Cited: 8
Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds
Maria João Ramalho, Stéphanie Andrade, Joana A. Loureiro, et al.
Drug Delivery and Translational Research (2019) Vol. 10, Iss. 2, pp. 380-402
Closed Access | Times Cited: 67
Research Progress on Alzheimer's Disease and Resveratrol
Yan Yan, Huihuang Yang, Yuxun Xie, et al.
Neurochemical Research (2020) Vol. 45, Iss. 5, pp. 989-1006
Closed Access | Times Cited: 67
Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
Fiona Limanaqi, Francesca Biagioni, Carla L. Busceti, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3274-3274
Open Access | Times Cited: 62
Flavonoids in adipose tissue inflammation and atherosclerosis: one arrow, two targets
Manal Fardoun, Dina Maaliki, Tomáš Slabý, et al.
Clinical Science (2020) Vol. 134, Iss. 12, pp. 1403-1432
Open Access | Times Cited: 55
Coconut oil-based resveratrol nanoemulsion: Optimization using response surface methodology, stability assessment and pharmacokinetic evaluation
Sabna Kotta, Hibah M. Aldawsari, Shaimaa M. Badr-Eldin, et al.
Food Chemistry (2021) Vol. 357, pp. 129721-129721
Closed Access | Times Cited: 55
Page 1 - Next Page

Scroll to top